Since 2014, UMR1227 has been strongly involved in European-scale projects, in particular through the European Union's Horizon 2020 framework programme for research and innovation and the joint public/private IMI initiative, which aims to accelerate the development of innovative medicines and patient access to them.
Current projects
![logo_3tr](/lbai/sites/lbai.www.univ-brest.fr/files/2021-06/3TR_logo_medium.png)
Taxonomy, Treatment, Targets and Remission. Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions
![logo_necessity_medium](/lbai/sites/lbai.www.univ-brest.fr/files/2021-06/NE_logo_medium-big.png)
New Clinical Endpoints in Primary Sjogren's Syndrome: An Interventional Trial based on stratifying patients
Learn more
Past projects
![logo_harmonicss](/lbai/sites/lbai.www.univ-brest.fr/files/2021-06/HSS_logo2_small.png)
HARMONIzation and integrative analysis of regional, national and international Cohorts on primary Sjögren’s Syndrome (pSS) towards improved stratification, treatment and health policy making
![logo_precisesads](/lbai/sites/lbai.www.univ-brest.fr/files/2021-06/PRECISESADS.jpg)
![logo_foreum](/lbai/sites/lbai.www.univ-brest.fr/files/2021-06/EU_FOREUM_logo_460x130.png)